Stock 543828 SUDARSHAN PHARMA INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sudarshan Pharma Industries Limited

Equities

543828

INE00TV01015

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 12:35:57 2024-05-10 am EDT 		5-day change 1st Jan Change
70 INR +0.84% Intraday chart for Sudarshan Pharma Industries Limited -7.44% -13.89%
Apr. 01 Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer CI
Mar. 30 1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024. CI

Valuation

Fiscal Period: March 2023
Capitalization 1 960
Enterprise Value (EV) 1 1,184
P/E ratio 19.1 x
Yield 0.54%
Capitalization / Revenue 0.21 x
EV / Revenue 0.26 x
EV / EBITDA 7.83 x
EV / FCF -2.66 x
FCF Yield -37.6%
Price to Book 1.33 x
Nbr of stocks (in thousands) 17,203
Reference price 2 55.80
Announcement Date 8/10/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 881.5 1,391 1,480 1,935 3,573 4,613
EBITDA 1 21.95 51.42 52.69 71.97 112.4 151.2
EBIT 1 21.46 50.06 49.22 65.74 104.9 143.1
Operating Margin 2.43% 3.6% 3.33% 3.4% 2.94% 3.1%
Earnings before Tax (EBT) 1 9.888 32.66 17.16 35.76 71.91 94.96
Net income 1 7.398 23.48 12.75 26.73 53.04 70.37
Net margin 0.84% 1.69% 0.86% 1.38% 1.48% 1.53%
EPS 2 1.152 1.860 0.8904 1.866 3.425 2.924
Free Cash Flow 1 -54.49 -88.66 -100.5 -97.25 -87.85 -444.9
FCF margin -6.18% -6.37% -6.79% -5.03% -2.46% -9.64%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - 0.3000
Announcement Date 3/1/19 6/3/19 8/13/21 8/13/21 3/6/23 8/10/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 102 109 195 286 304 224
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.636 x 2.123 x 3.708 x 3.976 x 2.701 x 1.481 x
Free Cash Flow 1 -54.5 -88.7 -100 -97.2 -87.8 -445
ROE (net income / shareholders' equity) 12.6% 17.2% 6.61% 12.6% 20.3% 10.8%
ROA (Net income/ Total Assets) 5.27% 7.72% 5.68% 5.23% 5.54% 4.84%
Assets 1 140.4 304.3 224.4 511.4 957.9 1,455
Book Value Per Share 2 7.100 13.10 13.90 15.70 20.40 42.00
Cash Flow per Share 2 0.0900 2.490 0.8900 0.8100 0.1600 4.870
Capex 1 0.57 35 40.4 13.2 16.6 143
Capex / Sales 0.06% 2.51% 2.73% 0.68% 0.46% 3.11%
Announcement Date 3/1/19 6/3/19 8/13/21 8/13/21 3/6/23 8/10/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SUDARSHAN PHARMA INDUSTRIES LIMITED Stock Sudarshan Pharma Industries Limited
-14.60% 20.49M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 543828 Stock
  4. Financials Sudarshan Pharma Industries Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW